BDSX CIK: 1439725

Biodesix, Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
43.6
FY22:
53.3
FY23:
39.7
FY24:
39.5
FY25:
32.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
32.5
FY22:
39.6
FY23:
59.4
FY24:
57.8
FY25:
55.0
Total assets
Change from FY21 to FY25
millions USD
FY21:
76.1
FY22:
92.9
FY23:
99.1
FY24:
97.2
FY25:
87.5

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
29.0
FY22:
22.8
FY23:
33.4
FY24:
14.3
FY25:
17.4
(negative)
Change from FY21 to FY25
millions USD
FY21:
27.4
FY22:
49.5
FY23:
61.1
FY24:
62.1
FY25:
72.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
19.7
FY22:
20.6
FY23:
4.58
FY24:
20.9
FY25:
−2.47
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
76.1
FY22:
92.9
FY23:
99.1
FY24:
97.2
FY25:
87.5

All amounts in millions USD Data source:SEC EDGAR